Alzheimer's Disease
  • Article
  • Nov 2 2022

Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.

  • Article
  • Oct 20 2022

The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.

  • Article
  • Oct 3 2022

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

  • Article
  • Sep 2 2022

The award exemplifies team science, helping to support 35 researchers across six different labs on four main projects on astrocytes.

  • Article
  • Aug 19 2022

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.

  • Article
  • Jul 22 2022

David Fardo, Stephen W. Wyatt Endowed Professor in the College of Public Health, is one of 14 University Research Professors for 2022-23. He conducts research on dementia-related neuropathologies.

  • Article
  • Jul 21 2022

College of Social Work's Allison Gibson, Ph.D., is working to address a lack of information and services for people with a diagnosis of mild cognitive impairment, which often leads to dementia and Alzheimer's disease.

  • Article
  • Jun 23 2022

A researcher at the UK’s Sanders-Brown Center on Aging is one of several experts in the field who recently discussed the use of two popular screening tests for dementia and Alzheimer’s disease.

  • Article
  • Jun 15 2022

A new UK College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer’s disease. 

  • Article
  • Jun 14 2022

Research published from the Sanders-Brown Center on Aging is providing the most definitive assessment yet of the prevalence of a form of dementia classified in 2019 and now known as LATE.